You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDK 4/6/cyclin/RB/E2F pathway

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Breast Cancer Trial (Ribociclib)

No longer available
  • Breast Cancer
  • (no location specified)
Feb 15, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Meningioma Trial in Phoenix (Abemaciclib, Placebo)

Not yet recruiting
  • Meningioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Jul 4, 2023

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

Recruiting
  • Advanced Breast Cancer
  • The combination of Dalpiciclib with physician-selected endocrine therapy
  • Chemotherapy selected by the physician
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Smoking, Cigarette, Smoking E-cigarette, Healthy Volunteer Trial in Philadelphia ([18F]NOS)

    Recruiting
    • Smoking, Cigarette
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 19, 2023

    Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

    Recruiting
    • Breast Cancer
    • Bowral, New South Wales, Australia
    • +37 more
    Aug 8, 2022

    Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

    Active, not recruiting
    Has Results
    • Advanced Breast Cancer
    • Beijing, Beijing, China
    • +6 more
    Jun 23, 2022

    Acute Respiratory Distress Syndrome, Hypoxemic Respiratory Failure, ARDS, Human Trial in Canada (TheraPPP)

    Recruiting
    • Acute Respiratory Distress Syndrome
    • +2 more
    • TheraPPP
    • Calgary, Alberta, Canada
    • +16 more
    Jul 21, 2022

    HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following

    Active, not recruiting
    • HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
    • Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
    • Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
    • Calgary, Alberta, Canada
    • +24 more
    Sep 12, 2022

    Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

    Not yet recruiting
    • Malignant Female Reproductive System Neoplasm
    • +3 more
    • Biopsy
    • +7 more
    • (no location specified)
    Nov 9, 2023

    Tumors Trial in Seoul (abemaciclib+paclitaxel)

    Active, not recruiting
    • Tumors
    • Seoul, Korea, Republic of
      Severance Hospital
    May 30, 2022

    Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

    Recruiting
    • Breast Cancer
    • CT scans
    • DEXA scan
    • Bronx, New York
      Montefiore Medical Center
    Jan 6, 2023

    Health-related Quality of Life in HIV-1 Infected Adults

    Active, not recruiting
    • HIV-1-infection
    • Montréal, Canada
    • +5 more
    Sep 22, 2022

    Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

    Recruiting
    • Chondrosarcoma
    • +2 more
    • Jacksonville, Florida
    • +3 more
    Apr 4, 2022

    2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2-

    Recruiting
    • Advanced Breast Cancer
    • +2 more
      • Ancona, Italy
      • +28 more
      Jul 27, 2022

      Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)

      Enrolling by invitation
      • Autism Spectrum Disorder
      • +6 more
      • SRS 2, CBCL, BRIEF-P
      • Penrith, New South Wales, Australia
      • +57 more
      Sep 18, 2022

      Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

      Not yet recruiting
      • Metastatic Breast Cancer
      • +4 more
      • CDK 4/6 inhibitors
      • Endocrine therapy
      • Helsinki, Finland
      • +11 more
      Sep 19, 2023

      B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • Biospecimen Collection
      • +19 more
      • (no location specified)
      Nov 8, 2023

      Prostate Cancer Trial in Canada (Palbociclib)

      Active, not recruiting
      • Prostate Cancer
      • Halifax, Nova Scotia, Canada
      • +6 more
      Jan 28, 2022

      Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Breast Carcinoma
      • Birmingham, Alabama
      • +12 more
      Feb 17, 2022

      PSMA PET/CT for Assessment of Recurrent Prostate Cancer

      Recruiting
      • Prostatic Neoplasms
      • Prostate Cancer
      • PSMA PET/CT scan
      • Vancouver, British Columbia, Canada
        BC Cancer
      Nov 15, 2021

      Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

      Not yet recruiting
      • Solid Tumors
      • (no location specified)
      May 17, 2023